{"name": "Acceleron Pharma",
 "permalink": "acceleron-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/acceleron-pharma",
 "homepage_url": "http://www.acceleronpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@acceleronpharma.com",
 "phone_number": "617-649-9200",
 "description": "Growth and Differentiation Factor",
 "created_at": "Wed Dec 16 01:46:54 UTC 2009",
 "updated_at": "Sat Dec 24 02:10:56 UTC 2011",
 "overview": "\u003Cp\u003EAcceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       82],
      "assets/images/resized/0006/9823/69823v1-max-150x150.png"],
     [[233,
       128],
      "assets/images/resized/0006/9823/69823v1-max-250x250.png"],
     [[233,
       128],
      "assets/images/resized/0006/9823/69823v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO, Founder",
    "person":
     {"first_name": "John",
      "last_name": "Knopf",
      "permalink": "john-knopf",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Anthony",
      "last_name": "Evnin",
      "permalink": "anthony-evnin",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Terry",
      "last_name": "McGuire",
      "permalink": "terry-mcguire-2",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0002/8631/28631v3-max-150x150.png"],
          [[184,
            184],
           "assets/images/resized/0002/8631/28631v3-max-250x250.png"],
          [[184,
            184],
           "assets/images/resized/0002/8631/28631v3-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Jean",
      "last_name": "George",
      "permalink": "jean-george",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Ed",
      "last_name": "Kania",
      "permalink": "ed-kania",
      "image":
       {"available_sizes":
         [[[103,
            150],
           "assets/images/resized/0004/5473/45473v1-max-150x150.jpg"],
          [[160,
            232],
           "assets/images/resized/0004/5473/45473v1-max-250x250.jpg"],
          [[160,
            232],
           "assets/images/resized/0004/5473/45473v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CFO",
    "person":
     {"first_name": "Peter",
      "last_name": "Courossi",
      "permalink": "peter-courossi",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$112M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2009/12/14/daily24-Acceleron-Pharma-grows-further-with-almost-11M-financing.html",
    "source_description": "Acceleron Pharma grows further with almost $11M financing",
    "raised_amount": 10951121.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 15,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.masshightech.com/stories/2008/06/16/daily7-Acceleron-to-grow-staff-manufacturing-in-Cambridge.html",
    "source_description": "Acceleron to grow staff, manufacturing in Cambridge",
    "raised_amount": 31000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 1,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.acceleronpharma.com/content/news/press-releases/detail.jsp/q/news-id/18",
    "source_description": "Acceleron Pharma Closes $30M Series B Financing",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 8,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Flagship Ventures",
         "permalink": "flagship-ventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0002/8188/28188v4-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0002/8188/28188v4-max-250x250.png"],
             [[323,
               74],
              "assets/images/resized/0002/8188/28188v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sutter Hill Ventures",
         "permalink": "sutter-hill-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0003/0838/30838v1-max-150x150.png"],
             [[250,
               23],
              "assets/images/resized/0003/0838/30838v1-max-250x250.png"],
             [[432,
               41],
              "assets/images/resized/0003/0838/30838v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2010/06/21/daily19-Acceleron-Pharma-pulls-in-84M-financing.html",
    "source_description": "Acceleron Pharma pulls in $8.4M financing",
    "raised_amount": 8400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Flagship Ventures",
         "permalink": "flagship-ventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0002/8188/28188v4-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0002/8188/28188v4-max-250x250.png"],
             [[323,
               74],
              "assets/images/resized/0002/8188/28188v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://www.masshightech.com/stories/2011/01/03/daily52-Acceleron-DMD-drug-target-draws-15M-grant.html",
    "source_description": "Acceleron DMD drug target draws $1.5M grant",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 6,
    "investments":
     []},
   {"round_code": "f",
    "source_url": "http://www.finsmes.com/2011/12/acceleron-pharma-raises-30m-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Acceleron Pharma Raises $30M in Funding",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 23,
    "investments":
     [{"company":
        {"name": "Celgene",
         "permalink": "celgene",
         "image":
          {"available_sizes":
            [[[113,
               99],
              "assets/images/resized/0006/8834/68834v1-max-150x150.png"],
             [[113,
               99],
              "assets/images/resized/0006/8834/68834v1-max-250x250.png"],
             [[113,
               99],
              "assets/images/resized/0006/8834/68834v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "128 Sidney Street",
    "address2": "",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Acceleron signs development deal with Shire",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 9,
    "source_url": "http://www.masshightech.com/stories/2010/09/06/daily23-Acceleron-signs-lucrative-development-deal-with-Shire-.html",
    "source_text": null,
    "source_description": "Acceleron signs lucrative development deal with Shire",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Acceleron Pharma",
      "permalink": "acceleron-pharma"}},
   {"description": "Acceleron Pharma, Shire Form $498M Drug Development Alliance ",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 10,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100910e69a00002\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "Acceleron Pharma, Shire Form $498M Drug Development Alliance  ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Acceleron Pharma",
      "permalink": "acceleron-pharma"}},
   {"description": "has appointed Kevin McLaughlin as senior vice president and chief financial officer ",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 29,
    "source_url": "http://www.masshightech.com/stories/2010/11/29/daily4-Qteros-vet-McLaughlin-named-Acceleron-CFO.html",
    "source_text": null,
    "source_description": "Qteros vet McLaughlin named Acceleron CFO",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Acceleron Pharma",
      "permalink": "acceleron-pharma"}},
   {"description": "Acceleron Pharma Extends Runway Through $242M Celgene Alliance ",
    "stoned_year": 2011,
    "stoned_month": 8,
    "stoned_day": 3,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110803e784001ry\u0026r=Rss\u0026s=DJFVW",
    "source_text": "",
    "source_description": "Acceleron Pharma Extends Runway Through $242M Celgene Alliance ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Acceleron Pharma",
      "permalink": "acceleron-pharma"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0006/9863/69863v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0006/9863/69863v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0006/9863/69863v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}